Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease.
CONCLUSIONS: At 24 months, our study found that patients with predominantly advanced infra-popliteal PAD who were treated with Absorb bioresorbable vascular scaffold reported improved clinical status and a low and durable rate of clinically driven target vessel failure extending out to 24 months.
PMID: 32921290 [PubMed - as supplied by publisher]
Source: Vascular - Category: Surgery Authors: Dia A, Venturini JM, Kalathiya RJ, Besser S, Estrada JR, Friant J, Paul J, Blair JE, Nathan S, Shah AP Tags: Vascular Source Type: research